| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Galectin Therapeutics Inc. (GALT) have been net sellers, shedding 98,287 shares worth roughly $496K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. GALT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.61M | $19.37M | - | |
| CFO | 100.0K | $345.0K | - | |
| CEO | 100.0K | $345.0K | - | |
| Dir | 60.0K | $207.0K | - | |
| Dir | 60.0K | $207.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 27,500 | $3.97 | $109,275.00 | -0.1% | -16.1% | -58.2% | |
| Apr 5, 2021 | Freeman Kevin D57 | Director | Buy | 5,000 | $2.04 | $10,200.00 | +20.0% | +40.1% | -21.7% | |
| Apr 1, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.16 | $21,600.00 | -0.2% | +45.5% | -28.2% | |
| Mar 1, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.31 | $23,100.00 | -0.2% | - | - | |
| Feb 2, 2021 | 10x Fund, L.P.85 | - | Sell | 10,000 | $2.04 | $20,400.00 | -0.2% | - | - | |
| Jan 11, 2021 | Amelio Gilbert F | Director | Sell | 60,000 | $2.17 | $130,200.00 | -49.7% | - | - | |
| Jan 4, 2021 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.23 | $22,300.00 | -0.2% | - | - | |
| Oct 13, 2020 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.97 | $29,700.00 | -0.2% | - | - | |
| Sep 4, 2020 | Uihlein Richard E | Director, 10% Owner | Buy | 10,000 | $2.55 | $25,500.00 | +0.1% | - | - | |
| Sep 4, 2020 | Freeman Kevin D57 | Director | Buy | 5,000 | $2.57 | $12,848.00 | +25.0% | - | - |